Prognostic factors for survival after autologous and allogeneic stem cell transplantation for Chronic Lymphocytic Leukemia (CLL): The EBMT experience

被引：0
|
作者：
Michallet, M
Brand, R
Dreger, P
Milligan, DW
Esteve, J
Kimby, E
Gratwohl, A
Apperley, J
Van Biezen, A
Niederwieser, D
机构：
来源：
BONE MARROW TRANSPLANTATION | 2001年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [21] Alemtuzumab Use and Survival After Reduced Intensity Allogeneic Stem Cell Transplantation in High-Risk Chronic Lymphocytic Leukemia (CLL)
    Ding, Wei
    Shanafelt, Tait D.
    Rabe, Kari
    Call, Timothy G.
    Zent, Clive S.
    Kay, Neil
    Inwards, David James
    Bowen, Deborah
    Litzow, Mark R.
    Slager, Susan L.
    Schwager, Susan
    Hogan, William J.
    [J]. BLOOD, 2011, 118 (21) : 1776 - 1776
  • [22] Impact of rituximab on immunomodulation and survival after non-myeloablative allogeneic stem cell transplantation (NST) for chronic lymphocytic leukemia (CLL).
    Khouri, IF
    Lee, MS
    Saliba, RM
    Korbling, M
    McMannis, JD
    Keating, MJ
    Champlin, RE
    [J]. BLOOD, 2003, 102 (11) : 727A - 727A
  • [23] Efficacy and prognostic implications of early autologous stem cell transplantation for poor-risk chronic lymphocytic leukemia (CLL).
    Dreger, P
    von Neuhoff, N
    Sonnen, R
    Kuse, R
    Seyfarth, B
    Lorenz, G
    Glass, B
    Schmitz, N
    [J]. BLOOD, 2000, 96 (11) : 483A - 483A
  • [24] Autologous stem cell transplantation for chronic lymphocytic leukemia
    Dreger, Peter
    Brand, Ronald
    Michallet, Mauricette
    [J]. SEMINARS IN HEMATOLOGY, 2007, 44 (04) : 246 - 251
  • [25] Single Institution Experience of Allogeneic Stem Cell Transplantation for Chronic Lymphocytic Leukemia
    Schwartz, Lauren
    Steinberg, Amir
    Afshar, Solmaz
    Galitzeck, Zachary
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S214 - S215
  • [26] Allogeneic Stem Cell Transplantation (alloHSCT) for Chronic Lymphocytic Leukemia (CLL) in the Era of Novel Agents
    Roeker, Lindsey E.
    Brown, Jennifer R.
    Dreger, Peter
    Lahoud, Oscar B.
    Eyre, Toby A.
    Brander, Danielle M.
    Skarbnik, Alan
    Coombs, Catherine C.
    Kim, Haesook T.
    Manchini, Steven T.
    Voorhees, Timothy J.
    Orchard, Kim H.
    Walter, Harriet S.
    Arumainathan, Arvind K.
    Sitlinger, Andrea
    Sauter, Craig S.
    Giralt, Sergio A.
    Perales, Miguel-Angel
    Mato, Anthony R.
    [J]. BLOOD, 2019, 134
  • [27] Allogeneic and autologous transplantation for chronic lymphocytic leukemia
    van Besien, K
    Keralavarma, B
    Devine, S
    Stock, W
    [J]. LEUKEMIA, 2001, 15 (09) : 1317 - 1325
  • [28] Allogeneic and autologous transplantation for chronic lymphocytic leukemia
    K van Besien
    B Keralavarma
    S Devine
    W Stock
    [J]. Leukemia, 2001, 15 : 1317 - 1325
  • [29] Allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia (CLL) with 17p deletion: A retrospective EBMT analysis
    Schetelig, Johannes
    van Biezen, Anja
    Caballero, Dolores
    Rodrigo, Martino
    Remes, Kari
    Garcia-Marco, Jose A.
    Volin, Liisa
    Perez-Simon, Jose A.
    Schmitz, Norbert
    Schwerdtfeger, Rainer
    Ganser, Arnold
    Soligo, Davide
    Mohr, Brigitte
    Stilgenbauer, Stephan
    Brand, Ronald
    Ehninger, Gerhard
    de Witte, Theo
    Dreger, Peter
    [J]. BLOOD, 2007, 110 (11) : 22A - 23A
  • [30] Risk factors for adverse outcome in patients with Chronic Lymphocytic Leukemia (CLL) undergoing Allogeneic Hematopoietic Cell Transplantation (alloHCT): A Retrospective EBMT Analysis
    Schetelig, J.
    de Wreede, L.
    Moreno, C.
    Andersen, N. Smedegaard
    van Gelder, M.
    Machaczka, M.
    Gramatzki, M.
    Dreger, P.
    Vitek, A.
    Karas, M.
    Michallet, M.
    Henseler, A.
    Bornhaeuser, M.
    Schoenland, S.
    Kroeger, N.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S107 - S108
12345